Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
BioPharma Dive reports: Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal.
Prime Medicine
Prime Medicine is a clinical-stage biotechnology company pioneering prime editing, a next-generation gene editing technology that can make precise edits to DNA without double-strand breaks. Its pipeline targets liver, ocular, and CNS genetic diseases.
Company Info
Sector:Biotechnology / Gene Editing
Headquarters:Cambridge, Massachusetts, USA
Founded:2019
Website:www.primemedicine.com/
Recent News
Prime wins gene editing patent fight with Beam
Prime wins gene editing patent fight with Beam (Fierce Biotech.)
Leadership Team
Careers & Job Openings